http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500810-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2009-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012500810-A |
| titleOfInvention | Method for treating abnormal blood glucose metabolism and glucose excursion |
| abstract | The present application relates to a pharmaceutical composition for reducing glucose excursion in a normal subject or a subject having an insulin related disorder or glycemic metabolism abnormality. The pharmaceutical composition comprises a therapeutically effective amount of a polar ionic insulin resistance-improving oral hypoglycemic agent, or a pharmaceutically acceptable salt thereof, and a monomeric form comprising a monomeric amphiphilic ionic compound Containing one or more active agent-containing layers, each containing a dry blend mixture comprising a plurality of amphiphilic compounds. Each dry blend mixture contains a sufficient amount of an amphiphilic ionic compound so that when contacted with an aqueous fluid, the amphiphilic ionic compound is a reverse ion containing a polar ionic insulin sensitizing oral hypoglycemic agent. Form micelles. The invention also improves therapeutically effective amounts of insulin resistance to sensitize pre-feeding (basal) insulin levels and / or reduce post-feeding glucose excursions in normal patients or patients with insulin-related disorders. It relates to the use of a modified release pharmaceutical composition comprising an oral hypoglycemic agent. |
| priorityDate | 2008-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 238.